Participants needed for eye drop safety study

Penn State Milton S. Hershey Medical Center’s Joseph Sassani, M.D., is studying the safety of eyedrops containing a medication that may facilitate corneal wound healing and which is approved by the U.S. Food and Drug Administration to be taken internally.

Researchers in the Department of Ophthalmology are conducting a study to document the safety of Naltrexone eye drops applied for one day to one eye of normal volunteers.

To volunteer for this study, participants should be age 21 to 50 years old; have not have had corneal or other ocular surface disease; and do not have systemic disease associated with ocular surface complications, including autoimmune or rheumatologic disorders or diabetes.

Compensation is provided.

For more information, call Susan Cobanoff at 717-531-3790.

This research, IRB 29780, has been approved by the Institutional Review Board, under federal regulations, at Penn State Hershey Medical Center, Penn State College of Medicine.

Contacts: 
Last Updated February 23, 2011